Category: Value in Health

As the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Value in Health provides a forum for researchers, health care decision makers, and policy makers to translate pharmacoeconomics and outcomes research into health care decisions. Value in Health contains original research articles in the areas of economic evaluation (including drugs and other medical technologies), outcomes research (“real world” treatment effectiveness, and patient-reported outcomes research), and conceptual, methodological, and health policy articles.

New Study Identifies Notable Differences in How 6 European Health Agencies Assess Real-World Data

Report Includes Findings from TLV (Sweden), NICE (UK), IQWiG (Germany), HAS (France), AIFA (Italy), and ZIN (Netherlands) Princeton, NJ—April 18, 2017—Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), announced today the publication of

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , ,

For Women at Risk of Hereditary Breast Cancer, Multigene Test Could Help Extend Life Expectancy

Princeton, NJ—April 17, 2017—Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), announced today the publication of new research indicating that testing for variants in 7 cancer-associated genes (versus the usual process of

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

New Research Findings: Health Costs for Children With Cancer Are Higher Than for Adolescents, Adults

Substantial Survival Gains in Children Mean That Treatment May Still Be Highly Cost Effective   Princeton, NJ—March 21, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of original research estimating the costs of cancer care

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , , ,

Introducing Novel Guidelines for Patient Engagement in Research

Using Real-World Examples to Inform the Integration of Patients as Full Research Partners in Outcomes Research   Princeton, NJ—March 20, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of suggested guidelines on establishing research partnerships with

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

ISPOR Publishes New Task Force Report on Constrained Optimization Methods

Research Methodology Can Help Identify Best Approaches to Achieve Optimal Health Outcomes for Patients Princeton, NJ—March 14, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new task force report, Constrained Optimization Methods in Health Services Research—An Introduction:

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , ,

ISPOR INITIATIVE ADVANCES HIGH-QUALITY VALUE ASSESSMENT FRAMEWORKS FOR HEALTH CARE INTERVENTIONS

Value in Health Themed Issue Examines the Development and Dissemination of High-Quality, Unbiased Frameworks   Princeton, NJ—February 27, 2017— The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a special theme issue of its flagship journal,

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , , , , , , , ,

“MAPPING STUDIES” IN COST-UTILITY ANALYSES: NEW RECOMMENDATIONS FROM ISPOR TASK FORCE

Guidance for the Consistent Application of Appropriate Analytical Methods   Princeton, NJ—February 14, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good

Posted in Announcements, ISPOR News & Press, Value in Health Tagged with: , ,

ISPOR RELEASES NEW TASK FORCE RECOMMENDATIONS FOR THE DEVELOPMENT OF CLINICIAN-REPORTED OUTCOME ASSESSMENTS

New Report Fills Long Standing Guidance Gap and Will Help Standardize ClinRO Assessments Princeton, NJ—February 13, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the

Posted in Announcements, ISPOR News & Press, Value in Health Tagged with: , ,

MOVING TOWARD UNIVERSAL HEALTH CARE COVERAGE: EXPLORING POLICY TRENDS IN COUNTRIES RICH AND POOR

Value in Health Series Examines Progress Toward Enacting an Integral Part of the Global Health Agenda Princeton, NJ—December 19, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a series of articles exploring trends in

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , , , , ,

ACCOUNTING FOR FUTURE PRICE REDUCTIONS CAUSED BY INCREASING ADOPTION OF MEDICAL DEVICES: IMPACT ON HTAs

Future Changes in Price and Uptake Affect Cost-Effectiveness Results  Princeton, NJ—October 10, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a report detailing a new modeling approach that explores the health technology assessment (HTA)

Posted in Announcements, ISPOR News & Press, Value in Health Tagged with: , , ,